FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Thursday

 

Researchers Identify 2 Cytokines Responsible for Chronic Flares in Autoimmune Diseases















Researchers have identified two factors that allow Th17 cells —  which drive MS and other autoimmune conditions — to form memory cells in the body and cause repeated symptom flare-ups.

Knowing the identity of the molecules, which are immune mediators called cytokines, will make it possible for scientists to search for ways to prevent T-cells from entering a chronic state.

“Interleukin-7 and -15 maintain pathogenic memory Th17 cells in autoimmunity” was published in the Journal of Autoimmunity.

More and more research points to Th17 T-cells as being responsible for the chronic nature of autoimmune diseases. In such conditions, a subset of T-cells form memory cells, and they circulate in the body and cause recurrent symptom flares. Scientists have yet to determine the events that cause the memory cells to form.

A research team from Schepens Eye Research Institute of Massachusetts Eye and Ear decided to take a closer look at the cytokines interleukin-7 (IL-7) and -15 (IL-15). Recent studies have suggested that they might be involved in autoimmune conditions.

By blocking IL-7 and IL-15 in a mouse model of the autoimmune dry eye disease, the researchers realized that these cytokines are crucial for Th17 cells’ survival. Without them, substantially fewer memory cells formed.

“We wanted to know the precise factors that maintain memory in Th17 cells so that we can better understand what is causing chronic autoimmune disorders,” Reza Dana, MD, director of the Cornea and Refractive Surgery Service at Massachusetts Eye and Ear, said in a press release.

The finding could be significant if researchers can find a way to translate it into treatments for human autoimmune diseases.

“By selectively targeting the production and expression of IL-7 and IL-15, we may be able to prevent the development of chronic autoimmune disorders,” said Dana, who also is the Claes H. Dohlman Professor of Ophthalmology at Harvard Medical School. “In the case of dry eye disease, many of the treatments are showing limited efficacy in patients that do not have a highly inflamed eye. Targeting the chronic, immune nature of autoimmune diseases may be a better strategy for controlling these conditions.”

Story Source: The above story is based on materials provided by MULTIPLESCLEROSISNEWSTODAY
Note: Materials may be edited for content and length


Go to Newer News Go to Older News